Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews · Airways

No studies found 0 · 0%GRADE not reported 1 · 16.7%Very low 0 · 0%Low 0 · 0%Moderate 3 · 50%High 2 · 33.3%

Moderate to severe exacerbations: high‐risk population · chronic obstructive pulmonary disease with predicted FEV1 of less than 80%

LABA/LAMA showed no clear difference in moderate to severe exacerbations: high‐risk population compared with LABA/ICS (moderate certainty).

1 finding from 1 review

Moderate to severe exacerbations: high‐risk population · chronic obstructive pulmonary disease with predicted FEV1 of less than 80%

1 finding from 1 review

Moderate to severe exacerbations: high‐risk population · chronic obstructive pulmonary disease with predicted FEV1 of less than 80%

LABA/ICS showed no clear difference in moderate to severe exacerbations: high‐risk population compared with LAMA (moderate certainty).

1 finding from 1 review

Moderate to severe exacerbations: high‐risk population · chronic obstructive pulmonary disease with predicted FEV1 of less than 80%

LABA/ICS leads to lower moderate to severe exacerbations: high‐risk population compared with LABA (high certainty).

1 finding from 1 review

Moderate to severe exacerbations: high‐risk population · chronic obstructive pulmonary disease with predicted FEV1 of less than 80%

LAMA leads to lower moderate to severe exacerbations: high‐risk population compared with LABA (high certainty).

1 finding from 1 review

Moderate to severe exacerbations: high‐risk population · chronic obstructive pulmonary disease with predicted FEV1 of less than 80%

LABA/LAMA showed no clear difference in moderate to severe exacerbations: high‐risk population compared with LAMA (moderate certainty).

1 finding from 1 review